Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09UNF
|
|||
Drug Name |
PMID28766366-Compound-Scheme24Paprotrain
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H11N3
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CN2)C(=CC3=CN=CC=C3)C#N
|
|||
InChI |
1S/C16H11N3/c17-9-13(8-12-4-3-7-18-10-12)15-11-19-16-6-2-1-5-14(15)16/h1-8,10-11,19H/b13-8+
|
|||
InChIKey |
YMYYQRZCCKBFBE-MDWZMJQESA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.